Home » Topics » Disease categories and therapies » Inflammatory

Inflammatory
RSS

BI-2545 shows promise for the unmet medical need in IPF treatment

Jan. 12, 2018

DS-28120313 shows in vivo efficacy as a potent orally active hepcidin production inhibitor

Dec. 13, 2017

Cardiac Hsl gene knockdown provides model of hypoxia tolerance

Dec. 1, 2017

Bristol-Myers Squibb initiates phase I trial of BMS-986235 in healthy subjects

Nov. 24, 2017

Spingotec Therapeutics divulges DPP3 inhibitors

Nov. 22, 2017

First-in-human results provided for TR-Pharm's anti-interleukin-1 biologic RPH-104

Nov. 15, 2017

New yohimbine analogues synthesized at the University of Florida

Nov. 15, 2017

Novel NLRP3 inflammasome inhibitors presented by IFM Therapeutics

Nov. 3, 2017

Novel leukotriene A-4 hydrolase inhibitors identified at Novartis

Oct. 31, 2017

Allergan presents new fMet-Leu-Phe receptor modulators

Oct. 30, 2017

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Feb. 3, 2025.
Today's news in brief
Briefs
BioWorld MedTech briefs for Jan. 30, 2026.
Centessa’s CNT-9982 shows promise for MDD
BioWorld Science
Orexin OX2 receptor agonists have demonstrated the ability to enhance wakefulness in rodent models, as well as in nonhuman primates and patients with narcolepsy...
First-in-class ADC targeting DEM-TXX shows high preclinical efficacy
BioWorld Science
Researchers at DEM Biopharma Inc. reported preclinical findings demonstrating the efficacy of DEM-301, a bifunctional antibody-drug conjugate (ADC) engineered to...
5-HT2R allosteric ligands attenuate cocaine use and seeking behavior
BioWorld Science
Serotonergic G-protein-coupled receptors (GPCRs), including the 5-HT2A receptor (5-HT2AR) and 5-HT2CR, are key regulators of cortical signaling pathways and...